Zhang Hui, Zheng Lijian, Feng Lei
Department of Neurosurgery, The First People's Hospital of Jining, Jining, Shandong 272011, P.R. China.
Exp Ther Med. 2019 Mar;17(3):1977-1984. doi: 10.3892/etm.2019.7198. Epub 2019 Jan 25.
Moyamoya disease (MMD) is a type of chronic cerebrovascular occlusion disease, which frequently occurs in East Asian populations, including pediatric and adult patients, and may lead to ischemic or hemorrhagic stroke, headache, epilepsy or transient ischemic attack. To date, the underlying mechanisms of MMD have remained to be fully elucidated, but certain studies have indicated that genetic factors may be an important component of its development. Cerebral angiography is the best approach for diagnosing MMD. However, with technological advances, non-invasive techniques are increasingly used to accurately evaluate MMD. MMD is commonly treated via surgery, and an increasing number of patients are benefitting from the intra- and extra-cranial revascularization. The present article provides a comprehensive review of MMD on the basis of previous research.
烟雾病(MMD)是一种慢性脑血管闭塞性疾病,常见于东亚人群,包括儿童和成人患者,可能导致缺血性或出血性中风、头痛、癫痫或短暂性脑缺血发作。迄今为止,烟雾病的潜在机制仍有待充分阐明,但某些研究表明,遗传因素可能是其发病的重要组成部分。脑血管造影是诊断烟雾病的最佳方法。然而,随着技术的进步,非侵入性技术越来越多地用于准确评估烟雾病。烟雾病通常通过手术治疗,越来越多的患者正从颅内和颅外血管重建术中受益。本文在以往研究的基础上对烟雾病进行了全面综述。